期刊
JOURNAL OF ORAL PATHOLOGY & MEDICINE
卷 39, 期 4, 页码 313-317出版社
WILEY
DOI: 10.1111/j.1600-0714.2009.00829.x
关键词
carbonic anhydrase IX; hypoxia-inducible factor 1 alpha; oral squamous cell carcinoma; prognosis
资金
- Deutsche Krebshilfe [106764]
- Wilhelm-Roux-Program of BMBF/NBL3 [FKZ: 14/27, 16/18]
Background: This study investigates the prognostic impact of the expression of hypoxia-inducible factor 1 alpha (Hif1 alpha) and carbonic anhydrase IX (CAIX) detected by immunohistochemistry in oral squamous cell carcinoma (OSCC). Methods: Statistical analysis of immunohistochemical results with clinical parameters including survival outcomes was performed for 80 OSCC patients. Results: Patients with a low expression of both proteins survived on average 54.8 months, whereas those with an increased expression of Hif1 alpha in their tumors combined with a low expression of CAIX survived on average only 37.6 months (P = 0.026). In multivariate Cox's regression hazard analysis, again patients with a low expression of Hif1 alpha/CAIX had the best prognosis, whereas patients with increased Hif1 alpha and low CAIX expression carried a 4.97-fold increased risk of tumor-related death (P = 0.042). Conclusion: A co-detection of low Hif1 alpha/CAIX expression is significantly correlated with a better prognosis for OSCC patients, which may have implications for therapy options for these patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据